Development and distribution of hemagglutinating antibody against the hepatitis B antigen in institutionalized populations.
D000328:Adult; D000367:Age Factors; D000410:Alanine Transaminase / Q000097:blood; D000906:Antibodies / Q000032:analysis*; D000917:Antibody Formation; D002353:Carrier State; D002674:Child, Institutionalized; D004314:Down Syndrome / Q000276:immunology; D005260:Female; D006385:Hemagglutination Inhibition Tests; D006386:Hemagglutination Tests; D006506:Hepatitis A / Q000097:blood / Q000201:enzymology / Q000276:immunology; D006509:Hepatitis B / Q000276:immunology; D006511:Hepatitis B Antigens / Q000032:analysis*; D006801:Humans; D005779:Immunodiffusion; D007122:Immunoelectrophoresis; D008607:Intellectual Disability / Q000276:immunology; D007902:Length of Stay; D008297:Male; D008875:Middle Aged; D012737:Sex Factors; D013997:Time Factors
D000906:Antibodies; D006511:Hepatitis B Antigens; D000410:Alanine Transaminase